Cancer-Fighting virus shows promise in Hard-to-Treat ovarian cancer
Disease control
Completed
This study tested a new immunotherapy called Olvi-Vec, which uses a modified virus to attack cancer cells, in 46 patients with ovarian cancer that had come back or stopped responding to standard treatments. The goal was to see if the treatment was safe and could slow tumor growth…
Phase: PHASE1, PHASE2 • Sponsor: Genelux Corporation • Aim: Disease control
Last updated Jun 16, 2026 23:35 UTC